Search results
PROMOTED
How do worsening heart events dictate the long-term outcomes of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and can earlier intervention influence the disease trajectory in ATTR-CM? In this new sub-analysis from ATTRibute-CM, recorded onsite at ESC Heart Failure Congress (HFA) 2026, Prof Marianna Fontana (University College London, London, UK) sheds further light onto these…
View more
HFA 2026: Updates on ATTR-CM
Author(s):
Marianna Fontana
,
Added:
4 weeks ago
Video Series
Author(s):
Nadira Hamid
,
Rahul P Sharma
Added:
7 months ago
TCT 2025 — Dr Nadira Hamid (Minneapolis Heart Institute, US) and Dr Rahul P Sharma (Stanford University, US) review the late-breaking trial data shaping the future of structural heart disease.The discussion highlights real-world results from TRISCEND and TRILUMINATE in tricuspid disease, 7-year PARTNER 3 durability outcomes in TAVR, national prevalence insights from the PREVUE-VALVE study, and…
View more
Karim Al-Azizi
Research Area(s) / Expertise:
Job title: Interventional Cardiologist and Structural Heart Disease Specialist
Author
Steven Yakubov
Research Area(s) / Expertise:
Job title: Director
Author
Author(s):
Raúl Ludeña
,
Raúl Ptaszynski Lanza
,
Ana Las Hayas
,
et al
Added:
2 months ago
William O’Neill
Job title: MD
Author
Ole De Backer
Research Area(s) / Expertise:
Job title: Professor of Medicine and Cardiology
Author
Robert Gooley
Author
Andrew Cook
Author
Darren Mylotte
Research Area(s) / Expertise:
Job title: Consultant Cardiologist
Author